The clinical and molecular cardiometabolic fingerprint of an exploratory psoriatic arthritis cohort is associated with the disease activity and differentially modulated by methotrexate and apremilast

OBJECTIVES: (1) To evaluate clinical and molecular cardiovascular disease (CVD) signs and their relationship with psoriatic arthritis (PsA) features and (2) to identify a clinical patient profile susceptible to benefit from methotrexate (MTX) and/or apremilast regarding CVD risk. METHODS: This cross...

Descripción completa

Detalles Bibliográficos
Autores principales: Arias de la Rosa, Ivan, López‐Montilla, Maria Dolores, Román‐Rodríguez, Cristobal, Pérez‐Sánchez, Carlos, Gómez‐García, Ignacio, López‐Medina, Clementina, Ladehesa‐Pineda, Maria Lourdes, Ábalos‐Aguilera, Maria del Carmen, Ruiz, Desiree, Patiño‐Trives, Alejandra Maria, Luque‐Tévar, Maria, Añón‐Oñate, Isabel, Pérez‐Galán, Maria Jose, Guzmán‐Ruiz, Rocio, Malagón, Maria M., López‐Pedrera, Chary, Escudero‐Contreras, Alejandro, Collantes‐Estévez, Eduardo, Barbarroja, Nuria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310593/
https://www.ncbi.nlm.nih.gov/pubmed/35233860
http://dx.doi.org/10.1111/joim.13447

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310593/
https://www.ncbi.nlm.nih.gov/pubmed/35233860
http://dx.doi.org/10.1111/joim.13447

Ejemplares similares